Alnaghy Sarah J, Deshpande Shrikant, Cutajar Dean L, Berk Kemal, Metcalfe Peter, Rosenfeld Anatoly B
Centre for Medical Radiation Physics, University of Wollongong.
J Appl Clin Med Phys. 2015 May 8;16(3):5113. doi: 10.1120/jacmp.v16i3.5113.
Verification of dose to the anterior rectal wall in helical tomotherapy to the prostate is important due to the close proximity of the rectal wall to the treatment field. The steep dose gradient makes these measurements challenging. A phantom-based study was completed, aimed at developing a system for measurement of anterior rectal wall doses during hypofractionated prostate stereotactic body radiotherapy (SBRT) utilizing tomotherapy delivery. An array of four dual MOSkinTM dosimeters, spaced 1 cm apart, was placed on a replica Rectafix® immobilization spacer device. This Perspex probe is a more rigid alternative to rectal balloons, to improve geometric reproducibility. The doses at each point were measured in real time and compared to doses calculated by the treatment planning system (TPS). Additionally, distance-to-agreement (DTA) measurements were acquired to assist in the comparison of measured and predicted doses. All dual MOSkin detectors measured dose to within ± 5% of the TPS at the anterior rectal wall. Whilst several points were outside of experimental error, the largest deviation from the TPS predicted dose represented a DTA of only 1.3 mm, within the acceptable DTA tolerance of 3 mm. Larger deviations of up to -11.9% were observed for the posterior and side walls; however, if acceptable DTA measurements are accounted for, then an agreement of 75% was observed. Although larger differences were observed at the other rectal wall locations, the overall effect of dose at these points was not as significant, given the lower doses. Despite the very high-dose gradient region, real-time measurements of the anterior rectal wall doses were within acceptable limits of TPS-predicted doses. The differences between measured and planned data were due to difficulties in precisely locating each detector on the TPS dose grid, which presented large variations in dose between CT voxels in regions of steep dose gradients. The dual MOSkin system would, therefore, be a useful device for detecting errors in real time, such as patient shifts or incorrect setup, during tomotherapy of the prostate.
在螺旋断层放射治疗前列腺癌时,由于直肠壁与治疗野距离很近,因此对直肠前壁剂量进行验证很重要。陡峭的剂量梯度使得这些测量具有挑战性。一项基于模体的研究完成了,旨在开发一种系统,用于在使用断层放射治疗进行前列腺立体定向体部放射治疗(SBRT)的低分割治疗期间测量直肠前壁剂量。将一组四个间隔1厘米的双MOSkinTM剂量计放置在Rectafix®固定间隔装置的复制品上。这种有机玻璃探头是直肠球囊的一种更坚固的替代品,以提高几何再现性。实时测量每个点的剂量,并与治疗计划系统(TPS)计算的剂量进行比较。此外,获取距离一致性(DTA)测量值以协助比较测量剂量和预测剂量。所有双MOSkin探测器在直肠前壁测量的剂量与TPS的误差在±5%以内。虽然有几个点超出了实验误差,但与TPS预测剂量的最大偏差仅为1.3毫米的DTA,在3毫米的可接受DTA容差范围内。在后壁和侧壁观察到高达-11.9%的较大偏差;然而,如果考虑可接受的DTA测量值,则观察到75%的一致性。尽管在直肠壁的其他位置观察到较大差异,但考虑到剂量较低,这些点的剂量总体影响并不显著。尽管存在非常高的剂量梯度区域,但直肠前壁剂量的实时测量在TPS预测剂量的可接受范围内。测量数据与计划数据之间的差异是由于难以在TPS剂量网格上精确放置每个探测器,这在陡峭剂量梯度区域的CT体素之间呈现出很大的剂量变化。因此,双MOSkin系统将是一种在前列腺断层放射治疗期间实时检测诸如患者移位或设置不正确等误差的有用设备。